Find a Tender
complete
Official procurement procedure
NHS National Generic Pharmaceuticals - Wave 16a
No classification published
Location not published
Published value
£799,311,560
Submission deadline 8 Jun 2026, 13:00 BST
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Generic Pharmaceuticals - Wave 16a". Published status: complete. Published value: £799,311,560. 3 published lots. Recorded submission deadline: 8 Jun 2026, 13:00 BST. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Closed 8 Jun 2026, 13:00 BST |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £799,311,560 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published1 Sept 2026, 15:46 BST | Last source update1 Sept 2026, 15:46 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-051c3a | ||
What is being bought
NHS National Framework for Generics Pharmaceuticals Wave 16a
Offer reference number: CM/PHG/24/5714
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/24/5714/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months)
CM/PHG/24/5714/02 Hospital only products:
DLN: 01/02/2027 to 31/01/2029 (24 months)
DNW: 01/02/2027 to 31/01/2029 (24 months)
CM/PHG/24/5714/03 Hospital only (housekeeping) products:
DCE/DSW: 01/02/2027 to 30/09/2027 (8 months)
DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)
What changed
From the official release history
- tender value changed
1 Sept 2026, 15:46 BST - Status changed to complete
1 Sept 2026, 15:46 BST - Official notice release published
1 Sept 2026, 15:46 BST - Submission deadline changed to published date
1 Sept 2026, 15:46 BST - Published value updated to £799,311,560
6 May 2026, 15:34 BST - Status changed to active
6 May 2026, 15:34 BST - Official notice release published
6 May 2026, 15:34 BST - Submission deadline changed to 8 Jun 2026, 13:00 BST
6 May 2026, 15:34 BST - Published value updated to £656,468,210
24 Apr 2026, 15:58 BST - Official notice release published
24 Apr 2026, 15:58 BST - Published value updated to £260,000,000
21 May 2025, 18:41 BST - Status changed to planned
21 May 2025, 18:41 BST - Official notice release published
21 May 2025, 18:41 BST - Buyer information updated
21 May 2025, 18:41 BST
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
1 Sept 2026, 15:46 BST - Submission deadline
8 Jun 2026, 13:00 BST - Award active
27 Aug 2026, 00:00 BST · £15,529,352 - Award active
27 Aug 2026, 00:00 BST · £393,331,872 - Award active
27 Aug 2026, 00:00 BST · £21,026,178
Commercial outcome and competition
Awards ASPIRE PHARMA LIMITED, BROWN & BURK UK LIMITED, CRESCENT PHARMA LIMITED, DRUGSRUS LIMITED, ENNOGEN HEALTHCARE INTERNATIONAL LIMITED, FARMAK PHARMACEUTICALS UK LTD, FLYNN PHARMA LIMITED, KENT PHARMA UK LIMITED, MERCURY PHARMACEUTICALS LIMITED, MILPHARM LIMITED, Medreich PLC, NECESSITY SUPPLIES LIMITED, NOVUMGEN LIMITED, RPH PHARMA LTD, SANDOZ LIMITED £15,529,352 · 27 Aug 2026, 00:00 BST · active AFT Pharma UK Limited, AGB Pharma (UK) Ltd, AOP Orphan Limited, ASCEND LABORATORIES (UK) LIMITED, ASCOT LABORATORIES LIMITED, ASPEN PHARMACARE UK LIMITED, ASPIRE PHARMA LIMITED, Accord UK Ltd, Aguettant Limited, Amarox Limited, Arcadia Pharma Limited, B. BRAUN MEDICAL LIMITED, BAXTER HEALTHCARE LIMITED, BOWMED IBISQUS LIMITED, BRANCASTER PHARMA LIMITED £393,331,872 · 27 Aug 2026, 00:00 BST · active ASCEND LABORATORIES (UK) LIMITED, Accord UK Ltd, Amarox Limited, B. BRAUN MEDICAL LIMITED, BAXTER HEALTHCARE LIMITED, BRANCASTER PHARMA LIMITED, BROWN & BURK UK LIMITED, CELIX PHARMA LTD, CIPLA (EU) LIMITED, CLINIGEN HEALTHCARE LIMITED, DAY LEWIS MEDICAL LIMITED, DR REDDY'S LABORATORIES (UK) LIMITED, FARMAK PHARMACEUTICALS UK LTD, FERRING PHARMACEUTICALS LTD, FRESENIUS KABI LIMITED £21,026,178 · 27 Aug 2026, 00:00 BST · active |
ContractsNo contract published |
Bid statistics bids: 49 (lot 1) finalStageBids: 47 (lot 1) smeFinalStageBids: 31 (lot 1) vcseFinalStageBids: 0 (lot 1) bids: 122 (lot 2) finalStageBids: 120 (lot 2) smeFinalStageBids: 81 (lot 2) vcseFinalStageBids: 0 (lot 2) bids: 66 (lot 3) finalStageBids: 66 (lot 3) smeFinalStageBids: 43 (lot 3) vcseFinalStageBids: 0 (lot 3) |
Buyer and organisations in this procedure
Showing primary 50 of 126 published organisations
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYAward and contract changes
Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published